Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.

Tobias Welponer* (First author), Daniela Weber (Co-author), Lisa Trattner (Co-author), Birgit Tockner (Co-author), Sepideh Aminzadeh-Gohari (Co-author), Victoria Leb-Reichl (Co-author), Anna Kaufmann (Co-author), Roland Zauner (Co-author), Monika Wimmer (Co-author), Verena Wally (Co-author), Thomas Felder (Co-author), Dirk Strunk (Co-author), Ulrich Koller (Co-author), Johann Bauer (Co-author), Barbara Kofler (Co-author), Christina Guttmann-Gruber (Last author), J Piñon Hofbauer* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

4 Citations (Web of Science)
Original languageEnglish
JournalJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
DOIs
Publication statusPublished - 2023

Keywords

  • HYPOXIA-INDUCIBLE FACTORS
  • CANCER
  • METABOLISM
  • RISK
  • HEAD
  • AMPK

Cite this